MARY GALETTI: Open Payments
NPI 1619586070 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 14 payments from 8 companies in 2025. Trend: 2023 $95 · 2024 $56 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $97 |
| Alkermes, Inc. | 3 | $61 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Axsome Therapeutics, Inc. | 1 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Luye Pharma (USA) Ltd. | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
| ABBVIE INC. | 1 | $16 |
Products named: ARISTADA, ABILIFY MAINTENA, COBENFY, ABILIFY ASIMTUFII, Auvelity, CAPLYTA, REXULTI, ERZOFRI EXTENDED-RELEASE.
Industry payments across IN — which companies pay providers there.
